Opinion | US negotiators face tough task to secure trade deal with China
With the tariff truce extended to November 10, US and Chinese negotiators can now focus on shaping a trade deal in the lead-up to a possible summit between US President…
With the tariff truce extended to November 10, US and Chinese negotiators can now focus on shaping a trade deal in the lead-up to a possible summit between US President…
Hangzhou-based Unitree won a total of 11 medals including four golds in the three-day event, which saw 280 teams from 16 countries compete in 26 sports, including kickboxing. The firm’s…
Xtep International Holdings’ interim earnings surged to a record, as the sportswear maker and distributor of the Saucony brand of running shoes benefited from the new-found popularity of marathons and…
Seven major insurers, including AIA, AXA and HSBC Life, on Monday signed a pledge and joined a Hong Kong Insurance Authority programme to promote the adoption of artificial intelligence in…
Zhejiang Leapmotor Technology, once a fringe player in China’s electric vehicle (EV) industry, is beating all its start-up rivals by sales and stock gains this year and analysts say there…
Chinese semiconductor firm Cambricon Technologies, seen as a potential future challenger to Nvidia, plans to raise nearly 4 billion yuan (US$560 million) for AI chip development, boosting its standing in…
Hong Kong stocks kicked off the week on a positive note, with investors focused on the earnings from more than 20 blue chips and Federal Reserve chair Jerome Powell’s speech…
Analysts and potential buyers warn that the bearish sentiments might weaken the effectiveness of the stimulus measures aimed at reviving the stagnant property market “The market sentiment is terribly weak…
Hong Kong lenders were expected to face a talent shortage in AI, green finance and expertise related to the Middle East and Asean markets over the next five years, according…
Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits, buoyed by novel drug roll-outs and revenue from technology licensing.…